Movatterモバイル変換


[0]ホーム

URL:


SG11201900602XA - Polymer-free drug eluting vascular stents - Google Patents

Polymer-free drug eluting vascular stents

Info

Publication number
SG11201900602XA
SG11201900602XASG11201900602XASG11201900602XASG11201900602XASG 11201900602X ASG11201900602X ASG 11201900602XASG 11201900602X ASG11201900602X ASG 11201900602XASG 11201900602X ASG11201900602X ASG 11201900602XASG 11201900602X ASG11201900602X ASG 11201900602XA
Authority
SG
Singapore
Prior art keywords
international
polymer
pct
rule
vascular stents
Prior art date
Application number
SG11201900602XA
Inventor
Ronald E Betts
Original Assignee
Biotronik Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotronik AgfiledCriticalBiotronik Ag
Publication of SG11201900602XApublicationCriticalpatent/SG11201900602XA/en

Links

Classifications

Landscapes

Abstract

OO cc O O () INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 22 March 2018 (22.03.2018) WIP0 I PCT onion °nolo olmoolioin om mu oimIE (10) International Publication Number WO 2018/050916 Al (51) International Patent Classification: A61L 31/08 (2006.01) A61L 31/16 (2006.01) (21) International Application Number: PCT/EP2017/073622 (22) International Filing Date: 19 September 2017 (19.09.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/396,248 19 September 2016 (19.09.2016) US 62/437,685 22 December 2016 (22.12.2016) US (71) Applicant: BIOTRONIK AG [CH/CH]; Ackerstrasse 6, 8180 Buelach (CH). (72) Inventor: BETTS, Ronald. E.; 6435 Muirlands Drive, La Jolla, California 92037 (US). (74) Agent: RANDOLL, Soren; BIOTRONIK SE & Co. KG, Woermannkehre 1, 12359 Berlin (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.1700) Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) (54) Title: POLYMER-FREE DRUG ELUTING VASCULAR STENTS Drug ElogPoct Sirolimus 6.4 Everolimus 6.7 Biolimus A9 7.4 CRC-015 9.4 FIG. 1 (57) : This application relates generally to the field of implants and more specifically to drug eluting vascular stents and methods of making and using same. Specifically, this technology relates to controlled release of drug from an implant and particular from a stent without the presence of polymer or alteration of the implant surface.
SG11201900602XA2016-09-192017-09-19Polymer-free drug eluting vascular stentsSG11201900602XA (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US201662396248P2016-09-192016-09-19
US201662437685P2016-12-222016-12-22
PCT/EP2017/073622WO2018050916A1 (en)2016-09-192017-09-19Polymer-free drug eluting vascular stents

Publications (1)

Publication NumberPublication Date
SG11201900602XAtrue SG11201900602XA (en)2019-02-27

Family

ID=59966729

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SG11201900602XASG11201900602XA (en)2016-09-192017-09-19Polymer-free drug eluting vascular stents

Country Status (8)

CountryLink
US (1)US20190388210A1 (en)
EP (1)EP3515517B1 (en)
JP (1)JP7074747B2 (en)
KR (1)KR102459201B1 (en)
CN (1)CN109715224B (en)
AU (1)AU2017328714B2 (en)
SG (1)SG11201900602XA (en)
WO (1)WO2018050916A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP3558407B1 (en)*2016-12-222023-03-15Biotronik AGDrug releasing coatings for medical devices and methods of making same
JP7005742B2 (en)*2017-07-262022-01-24鼎科医療技術(蘇州)有限公司 Surface liquefied drug coated balloon
EP3613449A1 (en)*2018-08-232020-02-26Biotronik AgImprovement of the polymer layer in degradable devices
JP7641222B2 (en)*2019-01-302025-03-06バイオトロニック アクチェンゲゼルシャフト Covered stents for localized drug delivery
CN110441193A (en)*2019-07-312019-11-12山东吉威医疗制品有限公司A kind of non-polymer medication coat FirebirdTM carries the measuring method of medicine density
JP7481134B2 (en)*2019-12-202024-05-10イビデン株式会社 Plant activators

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5527337A (en)1987-06-251996-06-18Duke UniversityBioabsorbable stent and method of making the same
US5059211A (en)1987-06-251991-10-22Duke UniversityAbsorbable vascular stent
US6515009B1 (en)1991-09-272003-02-04Neorx CorporationTherapeutic inhibitor of vascular smooth muscle cells
US6013853A (en)1992-02-142000-01-11The University Of Texas SystemContinuous release polymeric implant carrier
US5288711A (en)1992-04-281994-02-22American Home Products CorporationMethod of treating hyperproliferative vascular disease
US5342348A (en)1992-12-041994-08-30Kaplan Aaron VMethod and device for treating and enlarging body lumens
US5824048A (en)1993-04-261998-10-20Medtronic, Inc.Method for delivering a therapeutic substance to a body lumen
US5707385A (en)1994-11-161998-01-13Advanced Cardiovascular Systems, Inc.Drug loaded elastic membrane and method for delivery
US6099562A (en)1996-06-132000-08-08Schneider (Usa) Inc.Drug coating with topcoat
CA2178541C (en)1995-06-072009-11-24Neal E. FearnotImplantable medical device
GB9606452D0 (en)1996-03-271996-06-05Sandoz LtdOrganic compounds
EP1003444A4 (en)1997-08-082004-07-28Sunscope International IncMicroporous stent and implantation device
US6159488A (en)1997-08-142000-12-12Agricultural Research Org. Ministry Of Agriculture (Gov.)Intracoronary stents containing quinazolinone derivatives
US6153252A (en)1998-06-302000-11-28Ethicon, Inc.Process for coating stents
US6258121B1 (en)1999-07-022001-07-10Scimed Life Systems, Inc.Stent coating
AU2458501A (en)*2000-01-052001-07-16Imarx Therapeutics, Inc.Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
US7357854B1 (en)*2002-08-192008-04-15Advanced Cardiovascular Systems, Inc.Process for electropolishing a device made from cobalt-chromium
US7901451B2 (en)*2004-09-242011-03-08Biosensors International Group, Ltd.Drug-delivery endovascular stent and method for treating restenosis
US8124127B2 (en)*2005-10-152012-02-28Atrium Medical CorporationHydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9012506B2 (en)2004-09-282015-04-21Atrium Medical CorporationCross-linked fatty acid-based biomaterials
US20060127443A1 (en)*2004-12-092006-06-15Helmus Michael NMedical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US20070104753A1 (en)*2005-11-042007-05-10Aiden FlanaganMedical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
US20080175887A1 (en)*2006-11-202008-07-24Lixiao WangTreatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US8273402B2 (en)*2007-02-262012-09-25Medtronic Vascular, Inc.Drug coated stent with magnesium topcoat
US20080243241A1 (en)*2007-03-282008-10-02Zhao Jonathon ZShort term sustained drug-delivery system for implantable medical devices and method of making the same
US9327060B2 (en)*2009-07-092016-05-03CARDINAL HEALTH SWITZERLAND 515 GmbHRapamycin reservoir eluting stent
BR112012006925A2 (en)*2009-10-162016-06-07Hemoteq Ag use of a composition containing at least one solvent, at least one pharmacological agent and a transport mediator or a mixture of transport mediators, method for coating balloon catheters and balloon catheters
DE102010022588A1 (en)*2010-05-272011-12-01Hemoteq Ag Balloon catheter with a particle-free drug-releasing coating
US9056152B2 (en)*2011-08-252015-06-16Boston Scientific Scimed, Inc.Medical device with crystalline drug coating
CN102397119A (en)*2011-09-292012-04-04微创医疗器械(上海)有限公司Interventional medical instrument and preparation method thereof
WO2013091722A1 (en)*2011-12-232013-06-27Innora GmbhDrug-coated medical devices
DK2859001T3 (en)*2012-06-082016-05-30Biotronik Ag RAPAMYCIN 40-O-CYCLIC HYDROCARBESTERS, COMPOSITIONS AND PROCEDURES
CN104524646A (en)*2014-06-032015-04-22东莞天天向上医疗科技有限公司Biodegradable drug eluting stent and manufacturing method thereof

Also Published As

Publication numberPublication date
AU2017328714A1 (en)2019-01-24
AU2017328714B2 (en)2022-05-12
CN109715224B (en)2022-02-22
JP7074747B2 (en)2022-05-24
KR20190057059A (en)2019-05-27
EP3515517B1 (en)2022-02-16
JP2019528889A (en)2019-10-17
WO2018050916A1 (en)2018-03-22
US20190388210A1 (en)2019-12-26
EP3515517A1 (en)2019-07-31
KR102459201B1 (en)2022-10-27
CN109715224A (en)2019-05-03

Similar Documents

PublicationPublication DateTitle
SG11201900602XA (en)Polymer-free drug eluting vascular stents
SG11201805570WA (en)Systems and methods for long term transdermal administration
SG11201408092UA (en)Endoprosthesis and delivery device for implanting such endoprosthesis
SG11201806340YA (en)Zika virus vaccine
SG11201906297QA (en)Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201900163PA (en)Macrocycle kinase inhibitors
SG11201811431VA (en)Multispecific antibodies against cd40 and cd137
SG11201901442RA (en)Heart valve docking coils and systems
SG11201805320XA (en)Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration
SG11201901390TA (en)Tetracycline compounds and methods of treatment
SG11201805072PA (en)Nicotine powder delivery system
SG11201908326YA (en)Methods of treating neurodegenerative diseases
SG11201907889YA (en)Glycan-interacting compounds and methods of use
SG11201810485SA (en)Substituted carbonucleoside derivatives useful as anticancer agents
SG11202000136YA (en)Preparation comprising vonoprazan
SG11201809908TA (en)Stabilized glycopeptide antibiotic formulations
SG11201811221XA (en)Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof
CA3025288C (en)Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers
SG11201808306PA (en)Treatment of cancer with tg02
SG11201810280YA (en)Spiro-lactam nmda receptor modulators and uses thereof
SG11201900554YA (en)Spiro-lactam nmda modulators and methods of using same
SG11201809531SA (en)BINDING MOLECULES SPECIFIC FOR FCγGAMMA RIIA AND USES THEREOF
SG11201809875VA (en)Compositions and methods for treating spinal muscular atrophy
SG11201901188VA (en)Metal powder feedstocks for additive manufacturing, and system and methods for producing the same
SG11201900546UA (en)Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof

[8]ページ先頭

©2009-2025 Movatter.jp